OKUR - OnKure Therapeutics Inc Company Long-Term Liabilities

Public company logo of onkuretherapeutics.com (OKUR)

OnKure Therapeutics Inc (OKUR) coordinates global component supplies for the development of specific antitumor agents, mitigating risks by collaborating with various laboratories. This price action chart on GURU.Markets shows the metric at 0.00, while a staff of top biologists is attracted through grants and scientific freedom. The business relies on external contractors for molecule synthesis while retaining exclusive patent rights.

OnKure Therapeutics Inc (OKUR) Company Long-Term Debt: for the period 10/08/2024 - 11/01/2026

OnKure Therapeutics (OKUR) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price OnKure Therapeutics, Inc.|OKUR - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation OnKure Therapeutics|OKUR - Enterprise Value
- shareholders' equity book value data:
Net Asset Value per Share OnKure Therapeutics|OKUR - Company Book Value|Market Value to Book Value onkuretherapeutics.com|OKUR - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio OnKure Therapeutics Inc|OKUR - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio OnKure Therapeutics, Inc.|OKUR - Company Total Debt|Debts to Book Capitalization OnKure Therapeutics|OKUR - Company Long-Term Debt|Company Short-Term Loans and Borrowings OnKure Therapeutics|Immediate Liquidity onkuretherapeutics.com
- earnings and market multiples details:
OKUR - Company Net Income
Fundamental company valuation:OKUR (OnKure Therapeutics Inc)
Brand item of OnKure

The stability of OnKure Therapeutics Inc (OKUR) depends on the balance between funding elite biologists and the cost of borrowed capital. This indicator measures total liabilities with a maturity of more than one year, allowing for the determination of cash gap risks and the efficiency of the innovation financing structure through an assessment of the corporation's long-term loans and borrowings when analyzing the debt load trajectory.

Competitors of OnKure Therapeutics Inc (OKUR)

ONC: Company Long-Term Indebtedness|Halozyme - Company Long-Term Debts|Revolution Medicines Inc (RVMD) - Company Long-Term Liabilities|AAPG: Company Long-Term Debts|Long-Term Debt CG Oncology Therapeutics (CGON)|Company Long-Term Debt UroGen Pharma Ltd.|BCAX: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities PSNL (Personalis)|ERAS (Erasca Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts DCTH (Delcath)|YMAB - Company Long-Term Liabilities|AURA: Company Long-Term Liabilities|CADL - Company Long-Term Debts|Accuray (ARAY) - Company Long-Term Debt|SELLAS Life Sciences Group - Company Long-Term Loans and Borrowings|ACTU (Actuate Therapeutics, Inc) - Company Long-Term Debts|Long-Term Debt Citius Oncology Inc CTOR|Company Long-Term Debt TuHURA Biosciences, Inc. (HURA)|TARA - Long-Term Debt|Company Long-Term Debt Fate Therapeutics FATE|WHWK: Company Long-Term Indebtedness|TCRX - Company Long-Term Debt|CSBR - Company Long-Term Debts|XBIT (xbiotech.com) - Company Long-Term Liabilities|CEL-SCI (CVM) - Company Long-Term Debts|Company Long-Term Debt OS Therapies|RADX: Company Long-Term Loans and Borrowings|Company Long-Term Debts ARTV|ANL - Long-Term Debt|Veru Inc. - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings TPST|XLO: Company Long-Term Liabilities|Renovaro Inc. - Amount of Long-Term Liabilities|MURA: Company Long-Term Debts|Kairos Pharma - Company Long-Term Loans and Borrowings|GDTC (CytoMed Therapeutics Ltd) - Company Long-Term Debts|Long-Term Debt Curis Corp CRIS|Company Long-Term Debt Apollomics, Inc. (APLM)|THAR (Tharimmune Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts ADVB (Advanced Biomed)|Company Long-Term Debts Genprex Inc GNPX|CLDI - Company Long-Term Debt|Long-Term Liabilities SBFM|XBIO: Company Long-Term Debts|Long-Term Debt Salarius Pharmaceuticals Inc (SLRX)|Company Long-Term Liabilities PPBT|Company Long-Term Debts AON|Company Long-Term Liabilities BGNE (BeiGene, Ltd.)|Amount of Long-Term Liabilities CKPT|Company Long-Term Debts ELEV (Elevation Oncology, Inc.)|Long-Term Debt Volume iCAD Inc. (ICAD)|Ikena - Company Long-Term Debts|Notable Labs Corp (NTBL) - Company Long-Term Liabilities|viracta.com (VIRX) - Company Long-Term Debt|MOR - Long-Term Debt Volume|Company Long-Term Liabilities NAYA|AAPGV: Company Long-Term Loans and Borrowings